Completion of Scientific Advice discussion with Fimea
Pikralida announces successful completion of Scientific Advice discussion with the Finnish Medicines Agency Fimea for PKL-021. Agreement on Phase 1 clinical trial design. Poznan, Poland, March 27, 2023 – Pikralida sp. z o.o., biopharmaceutical c ...
Deep Tech Summit
On 15 and 16 November, we will participate in the Deep Tech Summit, which will be held in the Cambridge Innovation Center in Warsaw. The intention behind the event is to connect and educate: private investors seeking unique projects,start-up foun ...
Pikralida on the deeptech map!
We are very proud to announce that Pikralida has been included in the Deeptech Map in the Central European region. Technologies dubbed “deep tech” are defined as breakthrough solutions based on technological achievements that are unique, protected a ...
New trends in Polish and global pharmacy
Our Scientists: Hanna Kierońska, Katarzyna Rogut and Michał Kretkiewicz took part in the international scientific conference 'New trends in Polish and global pharmacy: science, business and modern education', held in Poznań on 29-30 September 2022. ...
Industries of tomorrow: medical
Joanna Lipner represented Pikralida at THURSDAY GATHERING, taking part in the debate and presenting the company during the pitching session. The topic of the debate, chaired by Izabela Kozakiewicz-Frańczak, was: “Industries of tomorrow: Medic ...
Pikralida receives the Eagle of Innovation award
Pikralida sp. z o.o. is one of the winners of the “Rzeczpospolita” Innovation Eagle awards in the category Start-up with potential Poland – Global Our start-up received an award for work dedicated to the discovery and development of small-molecu ...
EpiFix on the Innovation Map of the Ministry of Health
An innovative project implemented by Pikralida: “Use of matrix metalloproteinase inhibitor for the development of an innovative therapeutic method for preventing the development of post-injury and post-stroke epilepsy” has been included in the healt ...
BigPharma Day
Joanna Lipner represented Pikralida sp. zo.o. in a panel discussion at Big Pharma Day2022, an event organised this year by the CITTRU Technology Transfer Centre at the Jagiellonian University. Knowledge exchange and experience sharing is cruc ...
Pikralida at scientific conference
Anna Krause and Stanisław Pikul represented Pikralida at the 7th Scientific and Training Conference of the Polish Neurological Society held on 14-17 September in Lublin. A poster presenting the results of the in vivo research conducted as part of t ...
Pikralida in Science|Business magazine
Pikralida has been invited to have its say in Science|Busines magazine on the topic of the challenges and issues faced in Poland by companies dealing in innovative drug development. Polish biotechnology is seeking a solid foundation for future grow ...